No Data
No Data
Catalyst Watch: Spotlight on Tesla, Alphabet Earnings, AACR Drug Data, and Global PMI Reports
Craig-Hallum Downgrades Ironwood Pharmaceuticals(IRWD.US) to Hold Rating, Announces Target Price $1
Ironwood Pharma (IRWD) Was Downgraded to a Hold Rating at Craig-Hallum
Leerink Partners Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Maintains Target Price $1
Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Maintains Target Price $1
Jefferies Downgrades Ironwood Pharmaceuticals(IRWD.US) to Hold Rating, Cuts Target Price to $0.7